1. Lowe VJ, Duhalongsed FG, Patz EF, Delong DM, Hoffman JM, Wolfe WG, et al. Pulmonary abnormalities and PET data analysis: A retrospective study. Radiology. 1997. 202:435–439.
2. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med. 1994. 35:1771–1776.
3. Goo JM, Im JG, Do KH, Kim KW, Chung JW, Park JH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000. 216:117–121.
4. Hubner KF, Buonocor E, Singh SK, Gould HR, Cotten DW. Characterization of chest masses by FDG positron emission tomography. Clin Nucl Med. 1995. 20:293–298.
5. Shin L, Katz DS, Yung E. Hypermetabolism on F-18 FDG PET of multiple pulmonary nodules resulting from bronchiolitis obliterans organizing pneumonia. Clin Nucl Med. 2004. 29:654–656.
6. Gotway MB, Storto ML, Golden JA, Reddy GP, Webb WR. Incidental detection of thoracic sarcoidosis on whole-body 18 fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography. J Thorac Imaging. 2000. 15:201–204.
7. Konishi J, Yamazaki K, Tsukamoto E, Tamaki N, Onodera Y, Otake T, et al. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration. 2003. 70:500–506.
8. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med. 1994. 150:1423–1438.
9. Jung KJ, Lee KS, Kim TS, Chung MP, Choi DC, Kwon OJ. Simple pulmonary eosinophilia (Loeffler's syndrome): chest radiographic and CT findings. J Korean Radiol Soc. 2000. 42:83–90.
10. Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med. 1994. 35:164–167.
11. Kim Y, Lee KS, Choi DC, Primack SL, Im JG. The spectrum of eosinophilic lung disease: radiologic findings. J Comput Assist Tomogr. 1997. 21:920–930.
12. Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F] fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003. 30:267–273.
13. Kapucu LO, Meltzer CC, Townsend DW, Keenan RJ, Luketich JD. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med. 1998. 39:1267–1269.
14. Travis WD, Garg K, Franklin WA, Wistuba II, Sabloff B, Noguchi M, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005. 23:3279–3287.
15. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004. 45:19–27.
16. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 1993. 104:997–1002.
17. Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998. 39:1016–1020.
18. Coleman RE. PET in lung cancer. J Nucl Med. 1999. 40:814–820.
19. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000. 27:822–832.
20. Bedrossian CW, Greenberg SD, Williams LJ Jr. Ultrastructure of the lung in Loeffler's pneumonia. Am J Med. 1975. 58:438–443.